Search for dialysis centres here

Find a centre Log in to explore the world's most comprehensive database of dialysis centres for free!

Jobs in dialysis

dialysis.team.logo.small.000 Professional dialysis recruitment 

 

US label update for AstraZeneca/B-MS' Onglyza for renally-impaired diabetics - The Pharma Letter PDF Print

US label update for AstraZeneca/B-MS' Onglyza for renally-impaired diabetics
The Pharma Letter
The renal study investigated the safety and efficacy of Onglyza in patients with moderate to severe renal impairment or end-stage renal disease (ESRD). Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

and more »

...
 
Share |

Dialysis travel

Dialysis information

Global Dialysis

Copyright © 2026 Global Dialysis. All Rights Reserved.